Boston Scientific has released its next-generation Watchman FLX left atrial appendage closure device in Europe on a limited basis. The CE-marked device, designed for reducing the risk of stroke in patients with non-valvular atrial fibrillation, will be rolled out to more areas in the second half of the year.
Boston Scientific announces limited release of next-gen LAAC device
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.